Safety and Efficacy of CG-BM1 in Ischemic Stroke

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
1. To evaluate the safety and tolerability of CG-BM1 for the treatment of patients with Ischemic Stroke. 2. To observe the preliminary effectiveness of CG-BM1 in treating Ischemic Stroke patients.
Epistemonikos ID: e050de824658e87e9a8be48b04042fa4a91f3392
First added on: Oct 28, 2026